abiraterone has been researched along with Debility in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deol, ES; Fiala, MA; Luo, S; Mian, H; Sanfilippo, KM; Schoen, MW; Wildes, T | 1 |
1 other study(ies) available for abiraterone and Debility
| Article | Year |
|---|---|
Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer.
Topics: Aged; Dementia; Frailty; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome; Veterans | 2023 |